San Francisco startup Structure Therapeutics is likewise focusing on an oral, the moment-every day GLP-one drug called GSBR-1290—the drug surpassed Wall Road’s expectations in June when a mid-phase study confirmed average weight loss of around six% and it ideas to get started on An additional mid-stage demo toward the top of this yr—that foun